Dr. Babalola is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1513 Cleveland Ave Bldg 500
East Point, GA 30344Phone+1 404-752-1000Fax+1 404-756-5252
Education & Training
- Morehouse School of MedicineResidency, Surgery, 2002 - 2007
- Bassett Medical CenterInternship, Transitional Year, 2001 - 2002
- University of Benin Faculty of MedicineClass of 1990
Certifications & Licensure
- NC State Medical License 2014 - 2025
- OH State Medical License 2014 - 2025
- MI State Medical License 2013 - 2023
- GA State Medical License 2006 - 2016
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Patient Preferences for Benefit and Risk Associated With High Intensity Focused Ultrasound for the Ablation of Prostate Tissue in Men With Localized Prostate Cancer.Olufemi Babalola, David Gebben, Michelle E Tarver, Ting-Hsuan Joyce Lee, Shu Wang
Clinical Genitourinary Cancer. 2024-08-01 - Using Separate Single-Outcome Risk Presentations Instead of Integrated Multioutcome Formats Improves Comprehension in Discrete Choice Experiments.Matthew J Wallace, E Hope Weissler, Jui-Chen Yang, Laura Brotzman, Matthew A Corriere
Medical Decision Making. 2024-08-01 - 1 citationsNon-Fusion Versus Fusion Surgery in Pediatric Idiopathic Scoliosis: What Trade-Offs in Outcomes Are Acceptable for the Patient and Family?A Noelle Larson, Michelle Claire Marks, Juan Marcos Gonzalez Sepulveda, Peter O Newton, Vincent J Devlin
The Journal of Bone and Joint Surgery. American Volume. 2024-01-03
Press Mentions
- Healthcare Research: CBN Awards N234m Grants to 5 BeneficiariesMarch 10th, 2021
- Peer-Reviewed: Randomized Controlled Trial in Nigeria Shows Ivermectin Exhibits Positive Clinical Benefit in Mild to Moderate COVID-19February 19th, 2021
- Nigerian Investigations into Ivermectin Gain Momentum with Seemingly Promising Preliminary Results from Ivercovid StudyFebruary 2nd, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: